Oklo's Microreactor Push Sparks Debate Over Nuclear Investment Potential

Oklo (NYSE: OKLO), a developer of microreactors for modular nuclear power plants, has seen its stock price soar from $15.50 at its SPAC merger debut to approximately $48 as of April 2026. The company has yet to deploy any microreactors or generate significant revenue, yet its market capitalization now stands at $8.3 billion. Oklo's Aurora microreactor technology aims to address limitations of conventional nuclear reactors by offering a modular design that can be scaled up to 75 MWe per deployment. The company recently broke ground on its first Powerhouse reactor in Idaho and secured a contract with the U.S. Department of Defense for a reactor at Eielson Air Force Base in Alaska. Oklo's business model relies on partnerships, including a collaboration with Siemens Energy for turbine systems and a joint venture with Centrus Energy for nuclear fuel services. The U.S. Nuclear Regulatory Commission has approved Oklo's first materials license, and the Department of Energy has endorsed its nuclear safety design agreement for the Aurora reactor. While analysts project revenue could rise from less than $1 million in 2027 to $36 million in 2028, the company's lack of current revenue and high valuation raise concerns about its speculative nature. The Motley Fool Stock Advisor analysts have not included Oklo in their recommended list of top stocks, which has historically identified high-performing investments like Netflix and Nvidia. Potential investors should carefully consider the risks associated with Oklo's early-stage development and regulatory dependencies.